🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ixazomib and rituximab work in treatin...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-08-28
Trial ID
NCT04047797
Treatments Being Tested
This phase II trial studies how well daratumumab, ixazomib, and dexamethaso...
Status
Unknown
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-07-03
Trial ID
NCT03942224
Treatments Being Tested
The study seeks to investigate safety and efficacy of ixazomib (NINLARO), a...
Status
Recruiting
Location
Royal London Hospital, Barts Health NHS Foundation Trust
Start Date
2020-06-15
Trial ID
NCT03783416
Treatments Being Tested
The primary purpose of this study is to determine the overall response rate...
Status
Withdrawn
Location
CEHON Centro de Hematologia e Oncologia da Bahia
Start Date
2019-09-30
Trial ID
NCT03608501
Treatments Being Tested
This phase I/Ia trial finds the best dose and side effects of venetoclax gi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-08-03
Trial ID
NCT04847453
The purpose of this study is to determine whether the addition of oral ixaz...
Status
Completed
Location
University of Arkansas Medical Sciences
Start Date
2012-08-01
Trial ID
NCT01564537
Treatments Being Tested
This study will determine the safety profile, tolerability, and maximum tol...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2009-10-12
Trial ID
NCT00932698
Treatments Being Tested
The purpose of this study is to provide continued access of ixazomib and/or...
Status
Terminated
Location
Cedars Sinai Medical Center
Start Date
2012-12-26
Trial ID
NCT01659658
Treatments Being Tested
Study design: Randomised, controlled, multi-centre, open-label, phase III t...
Status
Recruiting
Location
Aberdeen Royal Infirmary
Start Date
2017-03-20
Trial ID
NCT03562169
This is a phase 1, 2-part, pharmacokinetic study in patients with advanced ...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01912222
Treatments Being Tested